Home
Investment Rounds
Compugen Raises 20 Million

Loading investment round...

The leading intelligence layer for the startup ecosystem. Over 25,000 AI startups, curated, scored, and agent-ready, backed by 14,000+ investors, 75,000+ people and 24,000+ funding rounds you can query in real time through our RAG API.

DR65 out of 100, Above median. Ahrefs DR. Open the scores section.Ahrefs DR: 65/100. Above median. Measured by Ahrefs. Median 44.·

eDR82 out of 100, Above median. Effective DR. Open the scores section.Effective DR: 82/100. Above median. Measured by StartupHub.ai. Median 68.·

Agent94 out of 100, Top 25%. Agent Readiness. Open the scores section.Agent Readiness: 94/100. Top 25%. Measured by StartupHub.ai. Median 41.·

Trust99 out of 100, Top 25%. Data Trust. Open the scores section.Data Trust: 99/100. Top 25%. Measured by StartupHub.ai. Median 61.·

API91 out of 100. API & MCP Security. Open the scores section.API & MCP Security: 91/100. Measured by StartupHub.ai.·

Moat28 out of 100, Bottom 25%. Reproducibility. Open the scores section.Reproducibility: 28/100. Bottom 25%. Graded by StartupHub.ai. Median 62.our own scores, refreshed daily

Questions or support: Help and contact

Product

Startups
Investors
Rankings
Trending
Watchlist
Pricing
Price match

Tools

Free Tools
Article to YouTube
Agent Readiness
Email Validator
API Docs
MCP Server

Company

About
Contact
AI News
Blog
How-to guides
Write for Us
Advertise

Legal

Privacy Policy
Terms
Affiliate Disclosure
security.txt
Sitemap
RSS

© 2026 StartupHub.ai. All rights reserved.

StartupHub.ai

Discover

Home
Search
Submit Profile
News
Videos
Jobs

Browse

Rankings
New Startups
Market Analysis
Comparison
Watchlist

Tools

Email Validator
DR Checker
Agent Readiness
Market Map MakerNew
All Free Tools

Company

Pricing
Advertise
API Docs
About
Publish Content

Home News Startups Investors

Compugen

Compugen header image

Compugen

1993Tel Aviv, Israel

Profile section

About

Compugen is a clinical-stage drug discovery and development company focused on identifying and developing novel drug candidates for oncology and immunology. They utilize their proprietary discovery platforms to identify new biological targets and develop innovative therapies for unmet medical needs.

Investors (1)

Cantor Fitzgerald

Round details

Amount$20M

AnnouncedDec 30, 2009

Tags

OncologyImmunologyLife Sciences

Source

Round announcement

genengnews.com

Round score

40/100

Mixed

A mixed round, some signals are off the norm.

Syndicate size
Single investor, limited external validation.
Insider conviction
All-new money, no prior investors re-upped.
Investor track record
Mostly newer or unproven managers.

Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.

vs. Oncology, Immunology, Life Sciences (5)

Round size in sector80th pct

$12Mthis round: $20M$20M

Compugen funding round · $20M raised · (2009) | StartupHub.ai